26
Participants
Start Date
June 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
September 30, 2008
ezetimibe
Blinded study medication (ezetimibe 10 mg in tablet form) will be taken orally once daily in the morning on rising. Single-blind ezetimibe placebo will be taken during the Run-In Period. Patients will be issued one bottle containing either active drug or placebo for each treatment period.
placebo
Blinded study medication (matched placebo) will be taken orally once daily in the morning on rising. Single-blind ezetimibe placebo will be taken during the Run-In Period. Patients will be issued one bottle containing either active drug or placebo for each treatment period.
Cholesterol Research Center, Berkeley
Collaborators (1)
Merck Schering-Plough
UNKNOWN
UCSF Benioff Children's Hospital Oakland
OTHER